Download PDF
Thromb Haemost 2001; 86(06): 1585-1586
DOI: 10.1055/s-0037-1616770
Letters to the Editor
Schattauer GmbH

Effect of Chronic Angiotensin II Type I Receptor Antagonism and Angiotensin Converting Enzyme Inhibition on Plasma Fibrinolytic Variables in Patients with Heart Failure

Andrew P. Davie
MRC Clinical Research Initiative in Heart Failure, University of Glasgow & Haemostasis, Thrombosis & Vascular Medicine Unit, University Department of Medicine, Glasgow Royal Infirmary, Glasgow, Scotland, UK
,
Ann Rumley
MRC Clinical Research Initiative in Heart Failure, University of Glasgow & Haemostasis, Thrombosis & Vascular Medicine Unit, University Department of Medicine, Glasgow Royal Infirmary, Glasgow, Scotland, UK
,
Gordon D.O. Lowe
MRC Clinical Research Initiative in Heart Failure, University of Glasgow & Haemostasis, Thrombosis & Vascular Medicine Unit, University Department of Medicine, Glasgow Royal Infirmary, Glasgow, Scotland, UK
,
John J.V. McMurray
MRC Clinical Research Initiative in Heart Failure, University of Glasgow & Haemostasis, Thrombosis & Vascular Medicine Unit, University Department of Medicine, Glasgow Royal Infirmary, Glasgow, Scotland, UK
› Author Affiliations
Further Information

Publication History

Received 09 April 2001

Accepted after resubmission 03 September 2001

Publication Date:
12 December 2017 (online)

Also available at
    Permissions and Reprints

 

 

  • References

  • 1 Wright RA, Flapan AD, Alberti KGMM, Ludlam CA, Fox KAA. Effects of captopril therapy on endogenous fibrinolysis in men with recent, uncomplicated myocardial infarction. J Am Coll Cardiol 1994; 24: 67-73.
    CrossrefPubMedGoogle Scholar
  • 2 Moriyama Y, Ogawa H, Oshima S, Takazoe K, Honda Y, Hirashima O, Arai H, Sakamoto T, Sumida H, Suefuji H, Kaikita K, Yasue H. Captopril reduced plasminogen activator inhibitor activity in patients after acute myocardial infarction. Jpn Circ J 1997; 61: 308-14.
    CrossrefPubMedGoogle Scholar
  • 3 Lottermoser K, Wostmann B, Weisser B, Hertfelder HJ, Schmitz U, Vetter H, Dusing R. Effects of captopril on fibrinolytic function in healthy humans. Eur J Med Res 1999; 4: 31-4.
    PubMedGoogle Scholar
  • 4 Jansson JH, Boman K, Nilsson TK. Enalapril related changes in the fibrinolytic system in survivors of myocardial infarction. Eur J Clin Pharmacol 1993; 44: 485-8.
    CrossrefPubMedGoogle Scholar
  • 5 Sakata K, Shirotani M, Yoshida H, Urano T, Takada Y, Takada A. Differential effects of enalapril and nitrendipine on the fibrinolytic system in essential hypertension. Am Heart J 1999; 137: 1094-9.
    CrossrefPubMedGoogle Scholar
  • 6 Goodfield NER, Newby DE, Ludlam CA, Flapan AD. Effects of acute angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure. Circulation 1999; 99: 2983-5.
    CrossrefPubMedGoogle Scholar
  • 7 Brown NJ, Agirbasli MA, Williams GH. Effect of activation and inhibition of the renin-angiotensin system on plasma PAI-1. Hypertension 1998; 32: 965-71.
    CrossrefPubMedGoogle Scholar
  • 8 Sayer JW, Gutteridge C, Syndercombe-Court D, Wilkinson P, Timmis AD. Circadian activity of the endogenous fibrinolytic system in stable coronary artery disease. effects of beta-adrenoceptor blockers and angiotensin-converting enzyme inhibitors. J Am Coll Cardiol 1998; 32: 1962-8.
    CrossrefPubMedGoogle Scholar
  • 9 Brown NJ, Agirbasli M, Vaughan DE. Comparative effect of angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor antagonism on plasma fibrinolytic balance in humans. Hypertension 1999; 34: 285-90.
    CrossrefPubMedGoogle Scholar
  • 10 Zehetgruber M, Beckmann R, Gabriel H, Christ G, Binder BR, Huber K. The ACE-inhibitor lisinopril affects plasma insulin levels but not fibrinolytic parameters. Thromb Res 1996; 83: 143-52.
    CrossrefPubMedGoogle Scholar
  • 11 Vaughan DE, Rouleau JL, Ridker PM, Arnold JM, Menapace FJ, Pfeffer MA. Effect of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. Circulation 1997; 96: 442-7.
    CrossrefPubMedGoogle Scholar
  • 12 Pedersen OD, Gram J, Jeunemaitre X, Bilaud E, Jespersen J. Does long-term angiotensin converting enzyme inhibition affect the concentration of tissue-type plasminogen activator inhibitor-1 in the blood of patients with a previous myocardial infarction. Coron Artery Dis 1997; 8: 283-91.
    CrossrefPubMedGoogle Scholar
  • 13 Soejima H, Ogawa H, Yasue H, Suefuji H, Kaikita K, Nishiyima K. Effects of imadipril therapy on endogenous fibrinolysis in patients with recent myocardial infarction. Clin Cardiol 1997; 20: 441-5.
    CrossrefPubMedGoogle Scholar